MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

CYTK — Cytokinetics Inc.

Nasdaq

Cytokinetics Inc.

CompareBack to Screener
$65.60
-0.02(-0.03%)
O
66.45
H
66.91
L
64.49
V
2.47M
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Cytokinetics Inc. Statistics

Total Valuation

Market Cap$9.12B
Enterprise Value$9.12B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding124.43M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ration/a
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ration/a
P/TBV Ration/a
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Enterprise Valuation

EV / Earnings-44,270.18
EV / Salesn/a
EV / EBITDA-53,396.18
EV / EBIT-52,815.52
EV / FCF-60,249.75

Financial Position

Current Ratio4.21
Quick Ration/a
Debt / Equity-1.48
Debt / EBITDA-7.16
Debt / FCF-8.08
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)24.93%
Return on Assets (ROA)-16.18%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$-306
Employee Count673
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Taxn/a
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+16.48%
50-Day Moving Average$73.62
200-Day Moving Average$70.15
Relative Strength Index (RSI)20.65
Average Volume (20 Days)2,083,066

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$16.80K
Operating Income-$183.62K
Pretax Income-$206.03K
Net Income-$206.03K
EBITDA-$170.82K
EBIT-$172.70K
Loss Per Share$-1.67

Balance Sheet

Cash & Cash Equivalents$129.84K
Total Debt$1.22M
Net Cash-$1.09M
Net Cash Per Share$-0.01
Equity (Book Value)-$826.57K
Book Value Per Share$-0.01
Working Capital$640.28K

Cash Flow

Operating Cash Flow-$139.74K
Capital Expenditures-$5.93K
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow-$151.39K
FCF Per Share$-0.00

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yieldn/a
FCF Yield0.00%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a